class I selective histone deacetylase inhibitors (Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences/Hefei University of Technology/Houston Methodist Hospital Research Institute/China Pharmaceutical University)

N/A

Report date: 2025/01/26 17:40:55
NME

Base Information

Drug Nameclass I selective histone deacetylase inhibitors (Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences/Hefei University of Technology/Houston Methodist Hospital Research Institute/China Pharmaceutical University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
China Registration ClassN/A

Develop Information

Other Information

ATC CodeN/A
Related LinksN/A